Bibliography
- GOLD HS, MOELLERING RC: Antimicrobial drugresistance. N Eng]. J Med. (1996) 335:1445–1453.
- MICHEL M, GUTMANN L: Methicillin-resistant Staphylo-coccus aureus and vancomycin -resistant en ter o co cci: therapeutic realities and possibilities. Lancet (1997) 349:1901–1906.
- HIRAMATSU K, ARITAKA N, HANAKI H et al.: Dissemina-tion in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet (1997) 350:1670–1673.
- HIRAMATSU K: The emergence of Staphylococcusaureus with reduced susceptibility to vancomycin in Japan. Am. J. Med. (1998) 104 (5A) :7S–10S.
- The World Health Report 1996: Fighting disease,fostering development. U.N. World Health Organisation (WHO), WHO Publications, Geneva (1996). DAVIES J: Inactivation of antibiotics and the dissemina-tion of resistance genes. Science (1994) 264:375-382. SWARTZ MN: Hospital-acquired infections: diseases with increasingly limited therapies. Proc. Natl. Acad. Sci. USA (1994) 91:2420–2427.
- SALYERS AA, AMABILE-CUEVAS CF: Why are antibiotic resistance genes so resistant to elimination? Antimi-crob. Agents Chemother. (1997) 41 :2321–2325.
- WALSH C: Molecular mechanisms that confer antibac-terial drug resistance. Nature (2000) 406 (6797):775–781.
- KNOWLES DJC: New strategies for antibacterial drug design. Trends Microbic)]. (1997) 5 (10):379–383.
- BAX RP: Antibiotic resistance: a view from the pharma-ceutical industry. Clin. Infect. Dis. (1997) 24:S151–S153.
- FALKOW S: What is a pathogen? ASM News (1997) 63 (7):359–365.
- LIPSITCH M, MOXON ER: Virulence and transmissibility of pathogens: what is the relationship? Trends Microbic)]. (1997) 5(0:31–37.
- KNOWLES D, PATOU G: 'Essentiality' testing: lookingfor new antimicrobial targets. CUIT. Infect. Dis. Rep. (1999) 1 (5):488–494.
- •This article reviews the current status of the search for new antimicrobial targets and discusses future developments and issues.
- TANG CM, HOOD DW, MOXON ER: Microbial genomesequencing and pathogenesis. CUIT. Opin. Microbial (1998) 1(1):12–16.
- MOIR DT, SHAW KJ, HARE RS, VOVIS GF: Genomics andantimicrobial drug discovery. Antimicrob. Agents Chemother. (1999) 43(3):439–446.
- BLACK T, HARE R: Will genomics revolutionise antimi-crobial drug discovery? CUIT. Opin. Microbial (2000) 3 (5):522–527.
- ROSAMUND J, ALLSOP A: Harnessing the power of the genome in the search for new antibiotics. Science (2000) 287:1973–1976.
- MAHAN MJ, SLAUCH JM, MEKALANOS JJ: Selection of bacterial virulence genes that are specifically induced in host tissues. Science (1993) 259:686–688.
- VALDIVIA RH, FALKOW S: Bacterial genetics by flow cytometry: rapid isolation of Salmonella typhimurium acid-inducible promoters by differential fluorescence induction. Mol. Mkrobiol. (1996) 22:367–378.
- VALDIVIA RH, FALKOW S: Fluorescence-based isolation of bacterial genes expressed within host cells. Science (1997) 277:2007–2011.
- HARRINGTON CA, ROSENOW C, RETIEF J: Monitoring gene expression using DNA microarrays. Cum Opin. Microbic)]. (2000) 3 (3) :285–291.
- WASHBURN MP, YATES JR III: Analysis of the microbial proteome. Curr. Opin. Microbic)]. (2000) 3(3):292–297.
- PANDEY A, MANN M: Proteomics to study genes and genomes. Nature (2000) 405 (6788):837–846.
- HENSEL M, SHEA JE. GLEESON C, JONES MD, DALTON E, HOLDEN DW: Simultaneous identification of bacterial virulence genes by negative selection. Science (1995) 269:400–403.
- CHIANG SL, MEKALANOS JJ, HOLDEN DW: In vivo genetic analysis of bacterial virulence. Ann. Rev. Microbic)]. (1999) 53:129–154.
- ••This article compares and contrasts the IVET, DFI and STMmethodologies for isolating bacterial virulence determi-nants, as well as the GAMBIT technique to identify in vitro essential genes.
- MAHAN MJ, TOBIAS JW, SLAUCH JM et al: Antibiotic based IVET selection for bacterial virulence genes that are specifically induced during infection of a host. Proc. Nati Acad. Sci. USA (1995) 92:669–673.
- CAMILLI A, BEATTIE D, MEKALANOS J: Use of genetic recombination as a reporter of gene expression. Proc. Natl. Acad. Sci. USA (1994) 91:2634–2638.
- SLAUCH JM, CAMILLI A: WET and RIVET: use of gene fusions to identify bacterial virulence factors specifi-cally induced in host tissues. Methods Enzymol. (2000) 326:73–96.
- LOWE AM, BEATTIE DT, DERESIEWICZ RL: Identification of novel staphylococcal virulence genes by in vivo expression technology. Mol. Microbial (1998) 27:967–976.
- •This paper is an early report of the application of IVET technology to the important Gram-positive pathogen S. aureus, where a recombination-type reporter system was employed.
- GAHAN CGM, HILL C: The use of listeriolysin to identify in vivo induced genes in the Gram-positive intracel-lular pathogen Listeria monocytogenes. Mol. Microbic)]. (2000) 36(2)498–507.
- PERRY RD: Signature-tagged mutagenesis and the hunt for virulence factors. Trends Microbial. (1999) 7(10385–389.
- SHEA JE, HOLDEN DW: Signature-Tagged mutagenesis helps identify virulence genes. ASM News (2000) 66 (1):15–20.
- SHEA JE, SANTANGELO JD, FELDMAN RG: Signature-tagged mutagenesis in the identification of virulence genes in pathogens. CUIT. Opin. Microbial. (2000) 3(5):451–458.
- ••This recent review article describes the current body ofliterature on the application of STM to pathogenic organisms.
- HOLDEN DW, HENSEL M: Signature tagged mutagenesis. In: Methods in Microbiology, Academic Press (1998) 27:359–370.
- CORMACK BP, GHORI N, FALKOW S: An adhesin of the yeast pathogen Candida glabrata mediating adherence to human epithelial cells. Science (1999) 285 (5427):578–582.
- MET J-M, NOURBAKHSH F, FORD CW, HOLDEN DW: Identification of Staphylococcus aureus virulence genes in a murine model of bacteraemia using signature-tagged mutagenesis. Mol. Microbiol. (1997) 26(2):399–407.
- COULTER SN, SCHWAN WR, NG EYVV et al.: Staphylo-coccus aureus genetic loci impacting growth and survival in multiple infection environments. Mol. Microbic)]. (1998) 30(2):393–404.
- POLISSI A, PONTIGGIA A, FEGER G et al: large-scale identification of virulence genes from Streptococcus pneumoniae. Infect. Immun. (1998) 66(12):5620–5629.
- •This paper describes the application of STM technology to the important Gram-positive pathogen S. pneumoniae.
- JONES AL, KNOLL KM, RUBENS CE: Identification of Streptococcus agalactiae virulence genes in the neonatal rat sepsis model using signature-tagged mutagenesis. Mol. Mkrobiol. (2000) 37:1444–1455.
Websites
- www.tigr.org/tdb/mdb The Institute for Genomic Research (TIGR) USA. Microbial databases (2000).
- www.sanger.ac.uk/Projects/Microbes The Sanger Centre, UK. Microbial sequencing projects (2000).